Overview

Imiquimod 5% Cream for the Treatment of Periocular Basal Cell Carcinoma

Status:
Unknown status
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
This study aimed to prove the efficacy and safety of the use of imiquimod 5% cream in the periorbital region.
Phase:
Phase 4
Details
Lead Sponsor:
University of Sao Paulo
Treatments:
Adjuvants, Immunologic
Imiquimod
Immunologic Factors